Videos |View More
Roswell Park Experts Provide Nerve Surgery for Pain Relief, Muscle Restoration
Lindsay Lipinski, MD, FAANS, FACS, walks through three different types of surgeries offered at Roswell Park Comprehensive Cancer Center for patients experience nerve pain or loss of nerve function, whether from cancer treatment or other health complications.
Roswell Park Opens Phase 2B Randomized Clinical Trial of Promising Brain Cancer Immunotherapy
Roswell Park Comprehensive Cancer Center is the first center to treat patients in a newly opened advanced-stage clinical trial utilizing the brain cancer vaccine SurVaxM, offering a new treatment option for patients who are dealing with ...
Roswell Park Neuro-Oncology Team Expands with Specially Trained Surgeon
Meet Lindsay Lipinski, MD, FAANS. Dr. Lipinski brings exertise in peripheral nerve tumors and entrapment neuropathies to the Roswell Park Neuro-Oncology Team.
News |View More
Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park
Congressman Kennedy announced $7,731,872 in funding for the Roswell Park Comprehensive Cancer Center to renovate its newly integrated biobank, the Roswell Park Biorepository, made possible through the Office of the Director of the National ...
Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
Region’s only Comprehensive Cancer Center earns maximum rating, marking five decades of consecutive NCI support.
Clinical Trial of Roswell Park’s SurVaxM Glioblastoma Vaccine Reveals Promising Results
Clinical Trial of Roswell Park’s SurVaxM Glioblastoma Vaccine Reveals Promising Results.
Roswell Park Comprehensive Cancer Center Professor of Neurosurgery Michael Ciesielski, PhD, presented the most recent findings from the completed phase 2A study of the immunotherapy SurVaxM at a poster session in June at the American Society ...
Roswell Park Opens Phase 2B Randomized Clinical Trial of Promising Brain Cancer Immunotherapy
First center to treat newly diagnosed glioblastoma patients as part of late-stage trial with SurVaxM
The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, known as SurVaxM.